Robert Shorr, Ph.D.
Dr. Robert Shorr was the vice president, science & technology, chief scientist at United Therapeutics, Unither; vice president of science & technology at Enzon. He served as associate director of the department of molecular pharmacology at Smithkline. He was co-founder and founder, respectively, of Altira Capital and Consulting LLC, and at Biochem. He is a board member of Brainstorm Cell Therapeutics and served as director of business development for the university’s center for advanced technology in biotechnology established by the State of New York at Suny Stony Brook; chairman of the scientific advisory board at Metabolic Research inc. and trustee at Tissue Engineering Charities, the Imperial College of London. Dr. Shorr also appointed as a member of the scientific advisory board for Vyteris.